HOME Top Market Reports Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021

Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: BT 4883

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The molecular cytogenetics market is projected to reach USD 2.52 Billion by 2021 from USD 1.55 Billion in 2016, at a CAGR of 10.1% from 2016 to 2021.

On the basis of product, the market is segmented into kits and reagents, instruments, consumables, and software and services. The kits and reagents segment is expected to account for the largest share of the global market in 2016; the increasing incidence of genetic disorders and cancer is a key market driver in this segment.

On the basis of technique, the market is segmented into comparative genomic hybridization (CGH), fluorescence in situ hybridization (FISH), in situ hybridization (ISH), and other techniques. CGH forms the largest and fastest-growing technology segment of this market, as the increasing laboratory automation will increase areas of application of CGH in molecular cytogenetics market.

Based on application, the market is segmented into genetic disorders, cancer, personalized medicine, and other applications. The genetic disorders segment accounts for the largest share of the global market in 2016; this segment is also expected to register the highest CAGR. Owing to the large applications of molecular cytogenetics instruments, in genetic disorders diagnosis, this application will grow at a moderate rate in the future.

Based on end users, the molecular cytogenetics market is segmented into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account for the largest share of the global market in 2016 and is expected to register a CAGR of 11.2% from 2016 to 2021.

Geographically, the global market is dominated by North America. Growth in the North American segment is primarily driven by the high incidence of genetic disorders and cancer, rapid growth in the aging population, and high healthcare expenditure.

The major players in the molecular cytogenetics market are F. Hoffmann-La Roche Ltd. (Switzerland) Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Oxford Gene Technology (U.K.), and Applied Spectral Imaging (U.S.).

Target Audience for this Report:

  • Manufacturers and Suppliers of Molecular Cytogenetics Instruments and Consumables
  • Clinical and Research Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes related to Molecular Cytogenetics Market

Value Addition for the Buyer:

This report provides insights into the global molecular cytogenetics market. It provides valuable information on the products, techniques, applications, end users, and regions in the market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their product offerings and understand strategies undertaken by them to be competitive in this market.

The above-mentioned information would help the buyer understand market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the molecular cytogenetics market into the following segments:

Molecular Cytogenetics Market, by Product & Service

  •  Kits and Reagents
  • Testing Kits
  • Probes
  • Fluorescent Affinity Reagents
  • Instruments
  • Consumables
  • Software and Services

Molecular Cytogenetics Market, by Technology

  • Comparative Genomic Hybridization (CGH)
  • Array-based CGH
  • Standard CGH
  • Florescence In Situ Hybridization (FISH)
  • In Situ Hybridization (ISH)
  • Other Techniques

Molecular Cytogenetics Market, by Application

  • Genetic Disorders
  • Cancer
  • Personalized Medicine
  • Other Applications

Molecular Cytogenetics Market, by End User

  • Clinical and Research Laboratories
  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others End Users

Molecular Cytogenetics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia
    • China
    • Japan
    • India
    • RoA
  • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
           1.3.1 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 24)
    3.1 Conclusion

4 Premium Insights (Page No. - 30)
    4.1 Molecular Cytogenetics: Market Overview
    4.2 Geographic Analysis: Molecular Cytogenetics Market, By Techniques
    4.3 Molecular Cytogenetics Market Size, By Application

5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Increasing Incidence of Genetic Disorders and Cancer
                    5.2.1.2 Growing Focus on Targeted Cancer Treatment
                    5.2.1.3 Increasing Aging Population and Subsequent Rise in Prevalence of Chronic Diseases
                    5.2.1.4 Increasing Penetration of Molecular Cytogenetics in Clinical Pathological Testing
           5.2.2 Market Restraints
                    5.2.2.1 High Cost of Advanced Instruments
                    5.2.2.2 Unfavourable Reimbursement Scenario
           5.2.3 Market Opportunities
                    5.2.3.1 Untapped Emerging Markets in Asia
           5.2.4 Market Trends
                    5.2.4.1 Transition From Fish to Array-Based Techniques

6 Molecular Cytogenetics Market, By Product (Page No. - 41)
    6.1 Introduction
    6.2 Kits & Reagents
           6.2.1 Testing Kits
           6.2.2 Probes
           6.2.3 Fluorescent Affinity Reagents
           6.2.4 Other Kits & Reagents
    6.3 Instruments
    6.4 Consumables
    6.5 Software & Services

7 Molecular Cytogenetics Market, By Technique (Page No. - 51)
    7.1 Introduction
    7.2 Comparative Genomic Hybridization
           7.2.1 Array-Based Comparative Genomic Hybridization
           7.2.2 Standard Comparative Genomic Hybridization
    7.3 Fluorescence in Situ Hybridization
    7.4 In Situ Hybridization
    7.5 Other Techniques

8 Molecular Cytogenetics Market, By Application (Page No. - 60)
    8.1 Introduction
    8.2 Genetic Disorders
    8.3 Cancer
    8.4 Personalized Medicine
    8.5 Other Applications

9 Molecular Cytogenetics Market, By End User (Page No. - 66)
    9.1 Introduction
    9.2 Clinical & Research Laboratories
    9.3 Academic Research Institutes
    9.4 Pharmaceutical and Biotechnology Companies
    9.5 Other End Users

10 Molecular Cytogenetics Market, By Region (Page No. - 72)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
     10.4 Asia
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 RoA
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 109)
     11.1 Introduction
     11.2 Strategic Overview
     11.3 Market Share Analysis
     11.4 Competitive Situation and Trends
             11.4.1 Collaborations, Agreements, and Partnerships
             11.4.2 New Product Launches
             11.4.3 Acquisitions
             11.4.4 Expansions
             11.4.5 Other Developments

12 Company Profiles (Page No. - 116)
(Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
     12.1 Introduction
     12.2 ABBott Laboratories, Inc.
     12.3 Agilent Technologies, Inc.
     12.4 Applied Spectral Imaging
     12.5 Bio-Rad Laboratories, Inc.
     12.6 Danaher Corporation
     12.7 Illumina, Inc.
     12.8 Oxford Gene Technology (OGT)
     12.9 Perkinelmer, Inc.
     12.10 F. Hoffmann-LA Roche Ltd.
     12.11 Thermo Fisher Scientific Inc.

*Details on Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 138)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (78 Tables)

Table 1 Prevalence of Genetic Disorders (2012)
Table 2 Incidence of Cancer, By Country (2012)
Table 3 Market Size, By Product, 2014–2021 (USD Million)
Table 4 Molecular Cytogenetics Kits and Reagents Market Size, By Type, 2014–2021 (USD Million)
Table 5 Molecular Cytogenetics Kits and Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 6 Market Size for Testing Kits, By Region, 2014–2021 (USD Million)
Table 7 Market Size for Probes, By Region, 2014–2021 (USD Million)
Table 8 Market Size for Fluorescent Affinity Reagents, By Region, 2014–2021 (USD Million)
Table 9 Market Size for Other Kits and Reagents, By Region, 2014–2021 (USD Million)
Table 10 Molecular Cytogenetics Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 11 Molecular Cytogenetics Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 12 Molecular Cytogenetics Software and Services Market Size, By Region, 2014–2021 (USD Million)
Table 13 Market Size, By Technique, 2014–2021 (USD Million)
Table 14 Comparative Genomic Hybridization Market Size, By Region, 2014–2021 (USD Million)
Table 15 Comparative Genomic Hybridization Market Size, By Type, 2014–2021 (USD Million)
Table 16 Array-Based Comparative Genomic Hybridization Market Size, By Region, 2014–2021 (USD Million)
Table 17 Standard Comparative Genomic Hybridization Market Size, By Region, 2014–2021 (USD Million)
Table 18 Fluorescence in Situ Hybridization Market Size, By Region, 2014–2021 (USD Million)
Table 19 in Situ Hybridization Market Size, By Region, 2014–2021 (USD Million)
Table 20 Other Molecular Cytogenetics Techniques Market Size, By Region, 2014–2021 (USD Million)
Table 21 Market Size, By Application, 2014–2021 (USD Million)
Table 22 Global Market Size for Genetic Disorders, By Region, 2014–2021 (USD Million)
Table 23 Market Size for Cancer, By Region, 2014–2021 (USD Million)
Table 24 Market Size for Personalized Medicine, By Region, 2014–2021 (USD Million)
Table 25 Other Molecular Cytogenetics Applications Market Size, By Region, 2014–2021 (USD Million)
Table 26 Market Size for Clinical and Research Laboratories, By Region, 2014–2021 (USD Million)
Table 27 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2014–2021 (USD Million)
Table 28 Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 29 Market Size, By Region, 2014–2021 (USD Million)
Table 30 List of Related Conferences Held in North America
Table 31 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 32 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 33 North America: Market Size, By Technique, 2014–2021 (USD Million)
Table 34 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 35 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 36 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 37 U.S.: Market Size, By Technique, 2014–2021 (USD Million)
Table 38 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 39 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 40 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 41 Canada: Market Size, By Technique, 2014–2021 (USD Million)
Table 42 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 43 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 44 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 45 Europe: Market Size, By Technique, 2014–2021 (USD Million)
Table 46 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 47 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 48 Asia: Market Size, By Country, 2014–2021 (USD Million)
Table 49 Asia: Market Size, By Product, 2014–2021 (USD Million)
Table 50 Asia: Market Size, By Technique, 2014–2021 (USD Million)
Table 51 Asia: Market Size, By Application, 2014–2021 (USD Million)
Table 52 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 53 China: Market Size, By Product, 2014–2021 (USD Million)
Table 54 China: Market Size, By Technique, 2014–2021 (USD Million)
Table 55 China: Market Size, By Application, 2014–2021 (USD Million)
Table 56 China: Market Size, By End User, 2014–2021 (USD Million)
Table 57 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 58 Japan: Market Size, By Technique, 2014–2021 (USD Million)
Table 59 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 60 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 61 India: Market Size, By Product, 2014–2021 (USD Million)
Table 62 India: Market Size, By Technique, 2014–2021 (USD Million)
Table 63 India: Market Size, By Application, 2014–2021 (USD Million)
Table 64 India: Market Size, By End User, 2014–2021 (USD Million)
Table 65 RoA: Market Size, By Product, 2014–2021 (USD Million)
Table 66 RoA: Market Size, By Technique, 2014–2021 (USD Million)
Table 67 RoA: Market Size, By Application, 2014–2021 (USD Million)
Table 68 RoA: Market Size, By End User, 2014–2021 (USD Million)
Table 69 RoW: Market Size, By Product, 2014–2021 (USD Million)
Table 70 RoW: Market Size, By Technique, 2014–2021 (USD Million)
Table 71 RoW: Market Size, By Application, 2014–2021 (USD Million)
Table 72 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 73 Growth Strategy Matrix, (2014–2016)
Table 74 Collaborations, Agreements, and Partnerships (2014–2016)
Table 75 New Product Launches (2014–2016)
Table 76 Acquisitions (2014–2016)
Table 77 Expansions (2014–2016)
Table 78 Other Developments (2014–2016)


List of Figures (47 Figures)

Figure 1 Global Molecular Cytogenetics Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Molecular Cytogenetics Market: Bottom-Up Approach
Figure 5 Molecular Cytogenetics Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Molecular Cytogenetics Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Global Molecular Cytogenetics Market Size, By Technique, 2016 vs 2021 (USD Million)
Figure 9 Global Molecular Cytogenetics Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 10 Global Molecular Cytogenetics Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Geographic Snapshot of the Global Molecular Cytogenetics Market
Figure 12 Global Molecular Cytogenetics Market to Witness Double-Digit Growth During the Forecast Period
Figure 13 Comparative Genomic Hybridization Segment to Dominate the Global Molecular Cytogenetics Market in 2016
Figure 14 Genetic Disorders Segment Will Continue to Dominate the Molecular Cytogenetics Market in 2021
Figure 15 Asia to Register the Highest CAGR During the Forecast Period
Figure 16 Molecular Cytogenetics Market: Drivers, Restraints, Opportunities, and Trends
Figure 17 Molecular Cytogenetics Market Segmentation, By Product
Figure 18 Kits and Reagents Will Continue to Dominate the Molecular Cytogenetics Products Market During the Forecast Period
Figure 19 Comparative Genomic Hybridization to Dominate the Molecular Cytogenetics Market During the Forecast Period
Figure 20 Array-Based CGH Will Continue to Dominate the CGH Market During the Forecast Period
Figure 21 Genetic Disorders Applications Segment to Dominate the Molecular Cytogenetics Market During the Forecast Period
Figure 22 Clinical and Research Laboratories to Dominate the Molecular Cytogenetics End-User Market During the Forecast Period
Figure 23 Molecular Cytogenetics Market, By Region (Market Size and Growth Rate), 2016
Figure 24 Molecular Cytogenetics Market in Europe to Grow at the Highest Rate During the Forecast Period
Figure 25 North America: Molecular Cytogenetics Market Snapshot
Figure 26 U.S. to Dominate the North American Market in 2016
Figure 27 Kits and Reagents, the Largest Product Segment in the North American Molecular Cytogenetics Market in 2016
Figure 28 Kits & Reagents are Estimated to Be the Largest Product Segment in the European Molecular Cytogenetics Market in 2016
Figure 29 Asia: Molecular Cytogenetics Market Snapshot
Figure 30 China is Estimated to Dominate the Asian Molecular Cytogenetics Market in 2016
Figure 31 Kits and Reagents to Grow at the Highest CAGR of the Asian Molecular Cytogenetics Market, By Product, in 2016
Figure 32 Kits and Reagents to Hold A Major Share of the Chinese Molecular Cytogenetics Market, By Product, in 2016
Figure 33 Kits and Reagents to Hold A Major Share of the Japanese Molecular Cytogenetics Market, By Product, in 2016
Figure 34 Kits and Reagents to Hold A Major Share of the Indian Molecular Cytogenetics Market, By Product, in 2016
Figure 35 Kits and Reagents to Hold A Major Share of the RoA Molecular Cytogenetics Market, By Product, in 2016
Figure 36 Kits and Reagents Segment to Grow at the Highest CAGR in the RoW Market
Figure 37 Collaborations, Agreements and Partnerships Were the Key Strategies Adopted By Players in the Molecular Cytogenetics Market
Figure 38 Molecular Cytogenetics Market Share Analysis, By Key Player, 2015
Figure 39 Geographic Revenue Mix of the Top Market Players
Figure 40 Company Snapshot: ABBott Laboratories, Inc.
Figure 41 Company Snapshot: Agilent Technologies, Inc.
Figure 42 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 43 Company Snapshot: Danher Corporation
Figure 44 Company Snapshot: Illumina, Inc.
Figure 45 Company Snapshot: Perkinelmer, Inc.
Figure 46 Company Snapshot: F. Hoffmann-LA Roche Ltd.
Figure 47 Company Snapshot: Thermo Fisher Scientific Inc.

The molecular cytogenetics market is projected to reach USD 2.52 Billion by 2021 from USD 1.55 Billion in 2016, at a CAGR of 10.1% from 2016 to 2021. The high incidence and large economic burden of genetic disorders and cancer and rise in healthcare expenditure has resulted in the increasing use of molecular cytogenetic products in clinical and research laboratories, academic research institutes, and pharmaceutical and biotechnology companies.

This market is segmented based on product, technique, application, end user, and region. On the basis of products, the market is segmented into kits and reagents, instruments, consumables, and software and services. The kits and reagents segment is expected to account for the largest share of the global market in 2016.

Based on techniques, the molecular cytogenetics market is segmented into comparative genomic hybridization, fluorescence in situ hybridization, in situ hybridization, and other techniques. Comparative genomic hybridization forms the largest and fastest-growing technology segment in the market.

Based on applications, the market is segmented into genetic disorders and cancer, personalized medicine, and other applications. Genetic disorders forms the largest and fastest-growing application segment in the market.

Based on end users, the molecular cytogenetics market is segmented into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account for the largest share of the global market in 2016.

Molecular Cytogenetics Market

The global molecular cytogenetics market is dominated by North America, followed by Europe. North America will continue to dominate the market in the forecast period. However, the market in Asia is expected to witness the highest CAGR, with the growth centered on China, Japan, and India.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo